OncoSec Medical Incorporated
ONCS
ONCS was delisted on the 23rd of June, 2023.
34 hedge funds and large institutions have $18.9M invested in OncoSec Medical Incorporated in 2018 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 10 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 5
11% less funds holding
Funds holding: 38 → 34 (-4)
26% less capital invested
Capital invested by funds: $25.6M → $18.9M (-$6.74M)
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NC
Nexthera Capital
New York
|
+$876K |
| 2 |
6CM
683 Capital Management
New York
|
+$478K |
| 3 |
BlackRock
New York
|
+$354K |
| 4 |
Millennium Management
New York
|
+$310K |
| 5 |
DS
DRW Securities
Chicago,
Illinois
|
+$175K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.59M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$507K |
| 3 |
CM
Crestline Management
Fort Worth,
Texas
|
-$379K |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$126K |
| 5 |
JP Morgan Chase
New York
|
-$94K |
ONCS Hedge Fund Activity: Q2 2018 in Review
34 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q2 2018, worth a combined $18.9M — down 26% from $25.6M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of ONCS and 7 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 10 added.
The largest buyer was Nexthera Capital, adding an estimated $876K. The largest seller was Point72 Asset Management, cutting an estimated $1.59M.
- 34 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q2 2018, down from 38 in Q1 2018.
- Funds reported $18.9M of OncoSec Medical Incorporated stock for Q2 2018, down 26% quarter-over-quarter.
- 7 funds opened new OncoSec Medical Incorporated positions in Q2 2018 and 10 closed out, a net change of -3 holders.
- The largest OncoSec Medical Incorporated buyer in Q2 2018 was Nexthera Capital, an estimated $876K added.
- The largest OncoSec Medical Incorporated seller in Q2 2018 was Point72 Asset Management, an estimated $1.59M sold.
Based on aggregated 13F filings for Q2 2018.